20172019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gabriella Moretti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Guarneri, V., Dieci, M. V., Bisagni, G., Frassoldati, A., Bianchi, G. V., De Salvo, G. L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C. A., Moretti, G., Griguolo, G., Vicini, R., Prat, A. & Conte, P. F., Jun 1 2019, In : Annals of Oncology. 30, 6, p. 921-926 6 p.

Research output: Contribution to journalArticle

Open Access
  • De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: Results of the PerELISA neoadjuvant study

    Guarneri, V., Dieci, M. V., Bisagni, G., Frassoldati, A., Bianchi, G. V., De Salvo, G. L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C. A., Moretti, G., Griguolo, G., Vicini, R., Prat, A. & Conte, P. F., 2019, In : Annals of Oncology. 30, 6, p. 921-926 6 p.

    Research output: Contribution to journalArticle

    Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

    Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, p. 1-9 9 p., 207.

    Research output: Contribution to journalArticle

  • Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.

    Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, 207.

    Research output: Contribution to journalArticle